Arvinas Inc (ARVN)

Apr 13, 2026

Treasury Yields: Can Arvinas Inc outperform in the next rally2026 Investor Takeaways & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 08, 2026

Why (ARVN) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Apr 08, 2026

Apr 08, 2026

JPMorgan Chase & Co. Has $1.83 Million Stock Holdings in Arvinas, Inc. $ARVN - MarketBeat

Apr 08, 2026

Apr 06, 2026

Arvinas, Inc. (ARVN) stock price, news, quote and history - Yahoo Finance Australia

Apr 06, 2026

Apr 06, 2026

Arvinas (ARVN) moves 6.9% higher: Will this strength last? - MSN

Apr 06, 2026

Apr 05, 2026

Arvinas, Inc. (ARVN) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 05, 2026

Apr 04, 2026

How The Arvinas (ARVN) Story Is Evolving As 2026 Neurology Catalysts Approach - Yahoo Finance

Apr 04, 2026

Apr 03, 2026

ARVN Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 03, 2026

Apr 02, 2026

Arvinas (NASDAQ:ARVN) Shares Down 5.1%Time to Sell? - MarketBeat

Apr 02, 2026

Apr 02, 2026

Arvinas Shares Surge 6.9% on Positive Pipeline Expectations - Intellectia AI

Apr 02, 2026

Apr 02, 2026

Arvinas (ARVN) Rises 6.9%: Can This Momentum Be Sustained? - Bitget

Apr 02, 2026

Apr 02, 2026

Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last? - Yahoo Finance

Apr 02, 2026

Mar 31, 2026

Pullback Watch: Can Arvinas Inc ride the EV waveMarket Trend Report & High Accuracy Trade Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Arvinas (ARVN) price target increased by 13.60% to 15.54 - MSN

Mar 30, 2026

Mar 30, 2026

Aug Summary: How does Arvinas Inc correlate with Nasdaq2026 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 30, 2026

Mar 27, 2026

ARVN Stock Price, Quote & Chart | ARVINAS INC (NASDAQ:ARVN) - ChartMill

Mar 27, 2026

Mar 26, 2026

Vanguard realignment leaves Arvinas (ARVN) ownership listed as 0 shares - Stock Titan

Mar 26, 2026

Mar 25, 2026

Arvinas patents new PROTACs for the degradation of BCL-6 - bioworld.com

Mar 25, 2026

Mar 22, 2026

Arvinas, Inc. (NASDAQ:ARVN) Receives Average Rating of "Hold" from Analysts - MarketBeat

Mar 22, 2026

Mar 21, 2026

Aug EndMonth: Is Arvinas Inc in a bullish channelMarket Growth Review & Weekly Breakout Watchlists - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

ARVN PE Ratio & Valuation, Is ARVN Overvalued - Intellectia AI

Mar 20, 2026

Mar 20, 2026

H.C. Wainwright reiterates Arvinas stock rating on trial data - Investing.com UK

Mar 20, 2026

Mar 20, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS), High Tide (HITI) and Arvinas Holding Company (ARVN) - The Globe and Mail

Mar 20, 2026

Mar 20, 2026

H.C. Wainwright reiterates Arvinas stock rating on trial data By Investing.com - Investing.com Australia

Mar 20, 2026

Mar 20, 2026

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), HOYA (OtherHOCPF) and TransMedics Group (TMDX) - The Globe and Mail

Mar 20, 2026

Mar 19, 2026

Arvinas’ chief medical officer Berkowitz sells $71k in shares By Investing.com - Investing.com South Africa

Mar 19, 2026

Mar 19, 2026

Noah Berkowitz Sells 6,435 Shares of Arvinas (NASDAQ:ARVN) Stock - MarketBeat

Mar 19, 2026

Mar 19, 2026

Arvinas’ chief medical officer Berkowitz sells $71k in shares - Investing.com UK

Mar 19, 2026

Mar 19, 2026

Arvinas (ARVN) CMO reports automatic RSU tax-withholding share sale - Stock Titan

Mar 19, 2026

Mar 19, 2026

Tranche Update on Arvinas, Inc.'s Equity Buyback Plan announced on September 17, 2025. - marketscreener.com

Mar 19, 2026

Mar 19, 2026

Arvinas (ARVN): Citigroup Raises Price Target to $21.00 and Main - GuruFocus

Mar 19, 2026

Mar 19, 2026

Arvinas (NASDAQ:ARVN) Price Target Raised to $21.00 at Citigroup - MarketBeat

Mar 19, 2026

Mar 19, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review

Mar 19, 2026

Mar 19, 2026

Arvinas (NASDAQ:ARVN) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat

Mar 19, 2026

Mar 19, 2026

BTIG Analyst Raises Price Target for Arvinas (ARVN) to $16 | ARV - GuruFocus

Mar 19, 2026

Mar 19, 2026

Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review

Mar 19, 2026

Mar 19, 2026

Arvinas reports positive Phase 1 data for Parkinson’s drug ARV-102 By Investing.com - Investing.com South Africa

Mar 19, 2026

Mar 19, 2026

Arvinas reports positive Phase 1 data for Parkinson’s drug ARV-102 - Investing.com India

Mar 19, 2026

Mar 18, 2026

BTIG raises Arvinas stock price target on positive trial data By Investing.com - Investing.com Australia

Mar 18, 2026

Mar 18, 2026

Arvinas, Inc. (ARVN) reports Q4 loss, misses revenue estimates - MSN

Mar 18, 2026

Mar 18, 2026

BTIG raises Arvinas stock price target on positive trial data - Investing.com

Mar 18, 2026

Mar 18, 2026

ARV-102 Data Strengthens Neurodegeneration Pipeline Prospects, Supporting Higher $16 Target and Buy Rating on Arvinas - TipRanks

Mar 18, 2026

Mar 18, 2026

Arvinas (ARVN) Reports Promising Phase 1 Trial Results for ARV-102 in Parkinson's Disease - GuruFocus

Mar 18, 2026

Mar 18, 2026

Truist reiterates Hold on Arvinas stock after Parkinson’s trial data By Investing.com - Investing.com Australia

Mar 18, 2026

Mar 18, 2026

Arvinas, Inc. Reports Forward-Looking Statements and Updates on ARV-102 Neurodegenerative Disease Program – March 2026 - Minichart

Mar 18, 2026